Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, not recruiting

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

NCT04291885

Conditions
Adenocarcinoma, Carcinoma, Carcinoma Neuroendocrine Skin, +18 more
Locations
  • Port Macquarie Base Hospital Port Macquarie, New South Wales, Australia
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
  • Melanoma Institute Australia Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View all 20 locations
View Trial Details
Active, not recruiting

Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)

NCT05696548

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Hokkaido University Hospital Hokkaido, Japan
  • Hyogo Cancer Center Akashi, Hyōgo, Japan
View Trial Details
Active, not recruiting

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

NCT06099782

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • Russell Medical ( Site 0160) Alexander City, Alabama, United States
  • Alaska Oncology and Hematology ( Site 0121) Anchorage, Alaska, United States
  • Highlands Oncology Group-Research Department ( Site 0133) Springdale, Arkansas, United States
  • Marin Cancer Care ( Site 0148) Greenbrae, California, United States
View all 45 locations
View Trial Details
Active, not recruiting

Pembrolizumab in Muscle-invasive Bladder Cancer

NCT05406713

Conditions
Carcinoma, Carcinoma, Transitional Cell, Localized Cancer, +5 more
Locations
  • City of Hope Duarte, California, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, not recruiting

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

NCT03093922

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced, +5 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, not recruiting

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

NCT04496739

Conditions
Atypical Hyperplasia of the Breast, Breast Carcinoma In Situ, Breast Diseases, +11 more
Locations
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Kaiser Permanente-Oakland Oakland, California, United States
View all 97 locations
View Trial Details

Related conditions